Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 11/30/11
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 04/19/17
End: 02/02/18
Due: 02/02/19
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Analysis of Growth Factors in Patients Undergoing Lucentis or Avastin Injections for Diabetic Macular Edema and Exudative Macular Degeneration | NCT01473251 | Vitreo-Retinal Associates, Michigan | user2@example.com | None | 2011-11-30 | 2014-04-30 | 2015-04-30 | - | - | 2025-07-14 |
| Analysis of Cytokines in Response to Treatment of Diabetic Macular Edema With 0.3mg Lucentis | NCT03097068 | Vitreo-Retinal Associates, Michigan | user2@example.com | None | 2017-04-19 | 2018-02-02 | 2019-02-02 | - | - | 2025-07-14 |